Tillkännagivande • Jul 04

Abacus Settlements, LLC & Longevity Market Assets, LLC (Abacus) completed the acquisition of East Resources Acquisition Company (NasdaqCM:ERES) from a group of shareholders in a reverse merger transaction.

Abacus Settlements, LLC & Longevity Market Assets, LLC (Abacus) entered into a non-binding letter of intent to acquire East Resources Acquisition Company (NasdaqCM:ERES) from a group of shareholders in a reverse merger transaction on July 18, 2022. Abacus Settlements, LLC & Longevity Market Assets, LLC entered into a definitive merger agreement to acquire East Resources Acquisition Company from a group of shareholders for approximately $640 million in a reverse merger transaction on August 29, 2022. As part of the Transactions, the holders of the limited liability company interests of Abacus will receive aggregate consideration of approximately $618.0 million, payable in a number of newly issued shares of ERES Class A common stock, par value $0.0001 per share with a value ascribed to each share of ERES Class A common stock of $10 and, to the extent the Aggregate Transaction Proceeds exceed $200 million, at the election of Abacus Members, up to $20 million of consideration payable in cash on a pro rata basis to Abacus Members. As per the amendment on October 14, 2022, the holders of the issued and outstanding limited liability company interests of Abacus will receive aggregate consideration of approximately $554.9 million, payable in a number of newly issued shares of ERES Class A common stock and, to the extent the Aggregate Transaction Proceeds exceed $200 million, at the election of Abacus Members, up to $20 million of consideration payable in cash on a pro rata basis to Abacus Members. ERES expects to issue 53.175 million shares of ERES Class A Common Stock to Abacus Members. Abacus owners will roll 100% of their existing equity holdings into the combined company and are expected to own approximately 70% of the combined company on a non-fully diluted basis immediately following the closing of the transaction, assuming no redemptions by ERES’s public stockholders. Transaction will result in Abacus becoming a publicly listed company. Upon closing of the transaction, the combined company will be named Abacus Life, Inc. and is expected to remain listed on Nasdaq under the new ticker symbol “ABAL.”Following the closing of the transaction, the existing management team of Abacus, led by Chief Executive Officer Jay Jackson, will continue to operate and manage Abacus, and is expected to head the post-combination company on closing. Besides Jackson, Abacus co-founders Matt Ganovsky and Scott Kirby would hold managing partner positions while co-founder Sean McNealy would be president and a director nominee of the merged company. Bill McCauley, who is Chief Financial Officer of Longevity Markets Assets LLC, would serve as Chief Financial Officer of the merged company. The other director nominees are Adam Gusky, Karla Radka, Thomas Corbett Jr., Cornelius Michiel van Katwijk, and Mary Beth Schulte.The transaction is subject to regulatory approvals, approval of the proposed transaction by stockholders of ERES and the satisfaction or waiver of other customary closing conditions. Transaction is also subject to all waiting periods and any extensions thereof applicable to the Transactions under the Hart-Scott-Rodino Act, and any commitments or agreements (including timing agreements) with any governmental entity not to consummate the Transactions before a certain date, must have expired or been terminated; after giving effect to the Transactions, ERES must have at least $5,000,001 of net tangible assets; the ERES Class A common stock to be issued in the Mergers must have been approved for listing by NASDAQ, subject only to official notice of issuance thereof; the directors and executive officers of ERES who are not continuing in their roles with the surviving company must have been removed from their respective positions or tendered their irrevocable resignations effective as of the Effective Time; approval of holders (members) of interests in Abacus. The transaction has been unanimously approved by the boards of both ERES and Abacus. As of December 20, 2022, Florida Office of Insurance Regulation has approved the transaction. The proposal to amend ERES’s amended and restated certificate of incorporation to extend the date by which the ERES has to consummate a business combination was approved by the requisite number of shares of ERES common stock voted at the special meeting on January 20, 2023. The Special Meeting of ERES stockholders to consider matters relating to the proposed Business Combination will be held on June 29, 2023.The transaction is anticipated to close as early as the fourth quarter of 2022. East Resources Acquisition Company’s stockholders approved the Second Extension Amendment, on January 23, 2023, the Sponsor deposited $94,249.55 (or $0.033 per share of Class A Common Stock that was not redeemed in connection with the Special Meeting (as defined below)) into the Trust Account on behalf of the Company and thereby extended the period the Company has to complete an initial business combination from January 27, 2023 to February 27, 2023. As of January 20, 2023, ERES’s stockholders voted to approve an extension of the period ERES has to complete an initial business combination (from January 27, 2023, to July 27, 2023). ERES shareholders voted to approve the business combination at a meeting held on June 29, 2023. As of January 23, 2023, East Resources Acquisition Company, issued a promissory note in the principal amount of up to $565,497.31 to East Sponsor, LLC, a Delaware limited liability company, pursuant to which the Sponsor agreed to loan the Company up to $565,497.31 in connection with the extension of the Company’s time to consummate a business combination from January 27, 2023, to July 27, 2023. As of May 16, 2023, the transaction is expected to close in second quarter of 2023.Aviditi Advisors is serving as exclusive strategic and financial advisor to ERES, and Ryan Maierson, Bryant Lee, Jim Cole, Michelle Carpenter, Gary Boss, Analisa Dillingham, Jason Cruise, Joseph Simei, Heather Deixler and Michelle Gross of Latham & Watkins LLP acting as legal counsels to ERES. Brian T. Casey of Locke Lord LLP is acting as Abacus’s legal counsel. Continental Stock Transfer & Trust Company acted as exchange agent to ERES. Deloitte & Touche LLP acted as accounting and financial, and tax due diligence provider to ERES. Northland Securities, Inc. acted as fairness opinion provide to ERES. ERES agreed to pay Northland a cash fee of $1 million, of which $0.1 million was due upon delivery of the fairness opinion and the remaining $0.9 million is due at the Closing. ERES has hired Morrow Sodali LLC to assist in the proxy solicitation process. ERES will pay Morrow a fee of $25,000 plus disbursements.Abacus Settlements, LLC & Longevity Market Assets, LLC (Abacus) completed the acquisition of East Resources Acquisition Company (NasdaqCM:ERES) from a group of shareholders in a reverse merger transaction on July 3, 2023. In connection with the completion of the business combination, ERES has been renamed “Abacus Life, Inc.” (“Abacus” or the “Company”), and its common stock and warrants are expected to commence trading on the Nasdaq Capital Market on July 5, 2023, under the ticker symbols “ABL” and “ABLLW”, respectively.

Total avkastning till aktieägarna	8.4%
Framtida utdelningsavkastning	8.3%
Utdelningstillväxt	n/a
Nästa utbetalningsdag för utdelning	n/a
Ex utdelningsdag	n/a
Utdelning per aktie	n/a
Utdelningsandel	50%

Segment	Utdelningsavkastning
Företag (ABX)	2.1%
Marknadens lägsta 25% (US)	1.4%
Marknad Topp 25% (US)	4.1%
Genomsnitt för branschen (Insurance)	2.6%
Prognosanalytiker (ABX) (upp till 3 år)	8.3%

Uppgifter	Senast uppdaterad (UTC-tid)
Analys av företag	2026/06/14 09:15
Aktiekurs vid dagens slut	2026/06/12 00:00
Intäkter	2026/03/31
Årlig intjäning	2025/12/31

Paket	Uppgifter	Tidsram	Exempel US-källa
Företagets finansiella ställning	10 år	Resultaträkning Kassaflödesanalys Balansräkning	SEC Form 10-K SEC Form 10-Q
Analytikernas konsensusuppskattningar	+3 år	Prognos för finansiella poster Analytikernas prismål	Rapporter från analytiker Blue Matrix
Marknadspriser	30 år	Aktiekurser Utdelningar, splittar och åtgärder	ICE Marknadsdata SEC Form S-1
Ägarskap	10 år	Största aktieägare Insiderhandel	SEC Formulär 4 SEC Formulär 13D
Förvaltning	10 år	Ledningsgrupp Styrelse och verkställande direktörer	SEC Form 10-K SEC Form DEF 14A
Viktiga utvecklingstendenser	10 år	Företagsmeddelanden	SEC Formulär 8-K

Analytiker	Institution
Matthew Howlett	B. Riley Securities, Inc.
Timothy D'Agostino	B. Riley Securities, Inc.
Randy Binner	B. Riley Securities, Inc.

Abacus Global Management Utdelningar och återköp

Utdelning kriterier kontrolleras 3/6

Viktig information

Senaste utdelnings- och återköpsuppdateringar

Abacus Global Management, Inc. (NYSE:ABX) announces an Equity Buyback for $20 million worth of its shares.

Abacus Global Management, Inc. Approves Annual Cash Dividend

Abacus Global Management, Inc. (NasdaqCM:ABL) announces an Equity Buyback for $20 million worth of its shares.

Abacus Global Management, Inc. (NasdaqCM:ABL) announces an Equity Buyback for $15 million worth of its shares.

Abacus Life, Inc. (NasdaqCM:ABL) announces an Equity Buyback for $15 million worth of its shares.

Recent updates

Abacus Global Management, Inc. (NYSE:ABX) completed the acquisition of unknown minority stake in Manning & Napier, Inc.

First quarter 2026 earnings: EPS and revenues miss analyst expectations

Abacus Global Management Announces Key Leadership Appointments, Effective April 17, 2026

Abacus Global Management, Inc., Annual General Meeting, Jun 13, 2026

Abacus Global Management, Inc. to Report Q1, 2026 Results on May 07, 2026

ABX: New Share Repurchase Plan Will Support Forward Upside Potential

Analysts Are Betting On Abacus Global Management, Inc. (NYSE:ABX) With A Big Upgrade This Week

Consensus revenue estimates increase by 15%, EPS downgraded

Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

ABX: Share Repurchase Plan Will Support Forward Upside Potential

ABX: Share Repurchase Plan Will Support Future Upside Potential

Abacus Global Management, Inc. to Report Q4, 2025 Results on Mar 12, 2026

ABX: Share Repurchase Program Will Support Future Upside Potential

Abacus Global Management, Inc. (NYSE:ABX) announces an Equity Buyback for $20 million worth of its shares.

ABX: Share Repurchases And Higher P/E Assumptions Will Support Upside Potential

ABX: Share Repurchases Will Support Improved Outlook And Higher Fair Value

Abacus Global Management, Inc.(NYSE:ABX) dropped from NASDAQ Composite Index

ABL: Index Additions Will Offset Lower Margin Outlook Going Forward

Investor sentiment improves as stock rises 19%

Abacus Global Management, Inc.'s (NASDAQ:ABL) 30% Jump Shows Its Popularity With Investors

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Revenue and earnings growth

Abacus Global Management, Inc. Approves Annual Cash Dividend

Abacus Global Management, Inc. (NasdaqCM:ABL) acquired Byron Udell & Associates, Inc.

Abacus Global Management, Inc. to Report Q3, 2025 Results on Nov 06, 2025

Abacus Global Management, Inc. announced that it expects to receive funding from Dynasty Financial Partners Inc.

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

New major risk - Shareholder dilution

Abacus Global Management, Inc. to Report Q2, 2025 Results on Aug 07, 2025

Co-Founder recently bought US$498k worth of stock

Abacus Global Management, Inc. (NasdaqCM:ABL) announces an Equity Buyback for $20 million worth of its shares.

Life Insurance Demand And Middle-Class Wealth Will Expand Market Opportunities

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Abacus Global Management, Inc., Annual General Meeting, Jun 12, 2025

Abacus Global Management, Inc. to Report Q1, 2025 Results on May 08, 2025

Abacus Global Management, Inc. (NasdaqCM:ABL) announces an Equity Buyback for $15 million worth of its shares.

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Abacus Life, Inc. to Report Q4, 2024 Results on Mar 27, 2025

New major risk - Shareholder dilution

Abacus Life, Inc. announced that it expects to receive $150 million in funding

Abacus Life, Inc. (NasdaqCM:ABL) completed the acquisition of Carlisle Management Company from Pacific Current Group Limited (ASX:PAC), Jose Esteban Casares and others.

Independent Director recently bought US$138k worth of stock

Abacus Life, Inc. has filed a Follow-on Equity Offering.

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Abacus Life, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Abacus Life Appoints Robert F. Phillips as Senior Vice President, Investor Relations and Corporate Affairs

Abacus Life, Inc. Appoints Corey McLaren as Managing Director, Capital Markets

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Abacus Life, Inc. (NasdaqCM:ABL) entered into a definitive agreement to acquire FCF Advisors LLC.

Abacus Life, Inc. (NasdaqCM:ABL) agreed to acquire Carlisle Management Company for $200 million.

Abacus Life, Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2024

Price target decreased by 16% to US$13.50

Abacus Life, Inc. has completed a Follow-on Equity Offering in the amount of $80 million.

First quarter 2024 earnings released

Abacus Life, Inc. has filed a Follow-on Equity Offering in the amount of $100 million.

Abacus Life, Inc., Annual General Meeting, Jun 13, 2024

Abacus Life, Inc. to Report Q1, 2024 Results on May 13, 2024

Abacus Life, Inc. Appoints Elena Plesco as Chief Capital Officer

Full year 2023 earnings released

Abacus Life, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Investor sentiment improves as stock rises 24%

Abacus Life, Inc. (NasdaqCM:ABL) announces an Equity Buyback for $15 million worth of its shares.

Independent Director recently bought US$74k worth of stock

New major risk - Financial position

Third quarter 2023 earnings released

Abacus Life, Inc. to Report Q3, 2023 Results on Nov 13, 2023

Abacus Life, Inc. Appoints Christopher Romaine as General Counsel

Investor sentiment deteriorates as stock falls 18%

New major risk - Shareholder dilution

Independent Director recently bought US$101k worth of stock